-
By Robert Huebscher |
January 5, 2010
Few accolades matter as much to a mutual fund as Morningstar's five-star designation. But, whether an investor can expect higher returns from higher rated funds is an important question.
-
By Robert Huebscher |
December 7, 2009
Unemployment will have a greater role in forecasting returns in this market than the lettered descriptor of the shape of the recovery. Whether we face inflation or deflation, too, will be largely dictated by unemployment.
-
By Robert Huebscher |
October 15, 2009
The case for economic recovery, at least one of the V-shaped variety, is difficult to make. First and foremost, one has to assume that the rise in unemployment will end, not just decelerate, as has been the case.
-
By Robert Huebscher |
September 3, 2009
One of the most ingrained investing precepts is that the longer one's time horizon, the more appropriate equities are as an asset class. But how quickly do the risks in equity investing diminish over time?
-
By Robert Huebscher |
June 24, 2009
Interest in Treasury Inflation Protected Securities (TIPS) is surging as investors seek protection against both inflation and deflation.
-
By Robert Huebscher |
June 1, 2009
The Wall Street Journal Journal of Indexes Forty years is the duration of the accumulation phase for most wage-earners. How was it that common stocks--the...
-
By Robert Huebscher |
April 1, 2009
The Barclay iShares Aggregate Bond ETF (AGG) returned 7.9% in 2008, far outpacing the performance of all equity indices. Moreover, this is not a temporary...
-
By Robert Huebscher |
March 1, 2009
Faced with declining asset values and the prospect of a deep and prolonged recession, approximately 30% of a recently surveyed group of independent registered investment...
-
By Robert Huebscher |
February 1, 2009
As CEO of Advisor Perspectives, one of the great privileges I enjoy is the opportunity to interview thought leaders in the investment industry. Since one...
-
By Robert Huebscher |
January 1, 2009
In an interview on November 21, legendary investor Jeremy Grantham, chairman and co-founder of GMO, declared that, "It's a nicely cheap market, but bear in...